Arvind Remedies to launch new drugs for Diabetes and Coronary heart disease

28 May 2014 Evaluate

Arvind Remedies has signed Memorandum of Understanding (MoU) with SRM University, Chennai, to transfer the patent right to undertake exclusive manufacturing and marketing of drugs for Type II Diabetes and Coronary heart disease.

These drugs will be manufactured in the form of tablets and will be launched in the domestic market by 2015 followed by the global market. The Diabetes drug is from the botanical source to ensure zero side effects on the health of patients.

Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×